Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.0579
+0.0039 (7.22%)
At close: Apr 28, 2025, 4:00 PM
0.0620
+0.0041 (7.08%)
Pre-market: Apr 29, 2025, 7:13 AM EDT

Petros Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
5.115.825.997.819.56
Upgrade
Revenue Growth (YoY)
-12.20%-2.83%-23.29%-18.29%-38.63%
Upgrade
Cost of Revenue
1.211.632.291.64.05
Upgrade
Gross Profit
3.94.193.76.215.51
Upgrade
Selling, General & Admin
8.759.2612.2115.5915.67
Upgrade
Research & Development
2.622.411.741.790.46
Upgrade
Operating Expenses
14.214.9519.5524.2622.8
Upgrade
Operating Income
-10.3-10.76-15.85-18.05-17.28
Upgrade
Interest Expense
-0.56-0.54-0.6-0.37-3.05
Upgrade
Interest & Investment Income
0.370.520.01--
Upgrade
Other Non Operating Income (Expenses)
-0.872.620.46--1.68
Upgrade
EBT Excluding Unusual Items
-11.35-8.16-15.97-18.42-22.01
Upgrade
Asset Writedown
-2.97--7.46--
Upgrade
Other Unusual Items
--3.399.43-
Upgrade
Pretax Income
-14.32-8.16-20.04-8.99-22.01
Upgrade
Income Tax Expense
-----1.43
Upgrade
Net Income
-14.32-8.16-20.04-8.99-20.59
Upgrade
Preferred Dividends & Other Adjustments
12.485.65---
Upgrade
Net Income to Common
-26.8-13.81-20.04-8.99-20.59
Upgrade
Shares Outstanding (Basic)
82211
Upgrade
Shares Outstanding (Diluted)
82211
Upgrade
Shares Change (YoY)
268.84%5.11%90.11%103.90%117.10%
Upgrade
EPS (Basic)
-3.34-6.35-9.68-8.25-38.55
Upgrade
EPS (Diluted)
-3.34-6.35-9.68-8.25-38.55
Upgrade
Free Cash Flow
-2.63-7.63-12.8-11.86-15.31
Upgrade
Free Cash Flow Per Share
-0.33-3.50-6.18-10.89-28.67
Upgrade
Gross Margin
76.28%71.98%61.79%79.52%57.67%
Upgrade
Operating Margin
-201.41%-184.84%-264.44%-231.05%-180.78%
Upgrade
Profit Margin
-524.20%-237.26%-334.40%-115.05%-215.35%
Upgrade
Free Cash Flow Margin
-51.40%-130.99%-213.57%-151.86%-160.16%
Upgrade
EBITDA
-7.46-7.48-10.25-11.17-10.62
Upgrade
EBITDA Margin
-146.02%-128.46%-171.01%-143.00%-111.11%
Upgrade
D&A For EBITDA
2.833.285.66.886.66
Upgrade
EBIT
-10.3-10.76-15.85-18.05-17.28
Upgrade
EBIT Margin
-201.41%-184.84%-264.44%-231.05%-180.78%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q